185 related articles for article (PubMed ID: 1560186)
1. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
Bonora E; Moghetti P; Querena M; Zenere M; Cacciatori V; Tosi F; Travia D; Zoppini G; Muggeo M
J Endocrinol Invest; 1992 Jan; 15(1):1-11. PubMed ID: 1560186
[TBL] [Abstract][Full Text] [Related]
2. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
Iori I; Bosi E; Manicardi E; Del Din G; Dini FL; Portioli I
Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):277-83. PubMed ID: 2640049
[TBL] [Abstract][Full Text] [Related]
4. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of gliquidone (author's transl)].
Zilker T; Ermler R; Henderkott U; Bottermann P
Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
[TBL] [Abstract][Full Text] [Related]
6. [Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
Podrouzková B; Krusová D
Vnitr Lek; 1992 Oct; 38(10):963-7. PubMed ID: 1481374
[TBL] [Abstract][Full Text] [Related]
7. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
[TBL] [Abstract][Full Text] [Related]
8. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
9. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
10. Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1
Zhang R; Zhou X; Sheng Q; Zhang Q; Xie T; Xu C; Zou Z; Dong J; Liao L
Eur J Pharmacol; 2021 Sep; 906():174221. PubMed ID: 34081903
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
14. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
Sonnenberg GE; Garg DC; Weidler DJ; Dixon RM; Jaber LA; Bowen AJ; DeChemey GS; Mullican WS; Stonesifer LD
Ann Pharmacother; 1997 Jun; 31(6):671-6. PubMed ID: 9184703
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
16. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Hosker JP; Burnett MA; Davies EG; Harris EA; Turner RC
Diabetologia; 1985 Nov; 28(11):809-14. PubMed ID: 3936738
[TBL] [Abstract][Full Text] [Related]
17. Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data.
Malaisse WJ
Drugs R D; 2006; 7(6):331-7. PubMed ID: 17073516
[TBL] [Abstract][Full Text] [Related]
18. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the second-generation sulfonylurea glipizide.
Lebovitz HE; Feinglos MN
Am J Med; 1983 Nov; 75(5B):46-54. PubMed ID: 6369967
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
